Abstract
Treating recurrent oropharyngeal malignancies poses a challenge. In many instances a conventional treatment such as surgery or radiation treatment is either not possible or would cause unacceptable morbidity. Photodynamic therapy could be an alternative treatment. The patients should be carefully assessed to confirm local disease and technical feasibility. While superficial tumors can be treated with light application to the surface, deeper lesions require interstitial light delivery strategies. In this chapter, details of different treatment strategies are described. There are a limited number of publications, especially about interstitial light delivery strategies. Our initial experiences are encouraging; however, the technique needs refinement and further research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nieuwenhuis EJ, Castelijns JA, Pijpers R, van den Brekel MW, Brakenhof RH, van der Waal I, Snow GB. Leemans CR Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node? Head Neck. 2002;24(3):282–9.
Ris HB, Altermatt HJ, Nachbur B, Stewart JC, Wang Q, Lim CK, Bonnett R, Althaus U. Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma. Int J Cancer. 1993;53(1):141–6.
Chang SC, Buonaccorsi G, MacRobert A, Bown SG. Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin. Int J Cancer. 1996;67:555–62.
Lodder WL, Teertstra HJ, Tan IB, Pameijer FA, Smeele LE, van Velthuysen ML, van den Brekel MW. Tumour thickness in oral cancer using an intra-oral ultrasound probe. Eur Radiol. 2011;21(1):98–106.
Karakullukcu B, van Oudenaarde K, Copper MP, Klop WM, van Veen R, Wildeman M, Bing TI. Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients. Eur Arch Otorhinolaryngol. 2011;268(2):281–8.
Biel M. Advances in photodynamic therapy for the treatment of head and neck cancers. Lasers Surg Med. 2006;38:349–55.
Biel MA. Photodynamic therapy of head and neck cancers. Methods Mol Biol. 2010;635:281–93.
Andrejevic-Blant S, Hadjur C, Ballini JP, Wagnières G, Fontolliet C, van den Bergh H, Monnier P. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval. Br J Cancer. 1997;76(8):1021–8.
Keller GS, Doiron DR, Fisher CU. Photodynamic therapy in otolaryngology-head and neck surgery. Arch Otolaryngol. 1985;111:758–61.
Feyh J, Goetz A, Muller W, Konigsberger R, Kastenbauer E. Photodynamic therapy in head and neck surgery. J Photochem Photobiol B. 1990;7:353–8.
Feyh J, Gutmann A, Leunig A. A photodynamic therapy in head and neck surgery. Laryngol Rhinol Otol. 1993;72:273–8.
Wenig BL, Kurtzman DM, Grossweiner L, Mafee JF, Harris DM, Lobraico RV, Prycz RA, Appelbaum EL. Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1990;116:1267–70.
Grossweiner LI, Hill JH, Lobraico RV. Photodynamic therapy of head and neck squamous cell carcinoma: optical dosimetry and clinical trial. Photochem Photobiol. 1987;46:911–7.
Schweitzer VG. Photodynamic therapy for treatment of head and neck cancer. Otolaryngol Head Neck Surg. 1990;102:225–32.
Gluckman JL. Hematoporphyrin photodynamic therapy: is there truly a future in head and neck oncology? Reflections on a 5-year experience. Laryngoscope. 1991;101:36–42.
Grant WE, Hopper C, Speight PM, Macrobert AD, Bown SC. Photodynamic therapy of malignant and premalignant lesions in patients with “field cancerization” of the oral cavity. J Laryngol Otol. 1993;107(12):1140–5.
Biel MA. Photodynamic therapy and the treatment of head and neck neoplasia. Laryngoscope. 1998;108:1259–68.
Poate TW, Dilkes MG, Kenyon GS. Use of photodynamic therapy for the treatment of squamous cell carcinoma of the soft palate. Br J Oral Maxillofac Surg. 1996;34:66–8.
Grosjean P, Savary JF, Wagnieres G, Mizeret J, Woodtli A, Fontolliet C, et al. Phototherapy of pharyngeal, oesophageal and bronchial early squamous cell carcinomas after sensitisation by tetra (m-hydroxyphenyl) chlorin (mTHPC). Med Chir Dig. 1996;25:411–3.
Copper MP, Tan IB, Oppelaar H, Ruevekamp MC, Stewart FA. Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2003;129:709–11.
D’Cruz AK, Robinson MH, Biel MA. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients. Head Neck. 2004;26:232–40.
Lorenz KJ, Maier H. Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan®) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients. Eur Arch Otorhinolaryngol. 2009;266(12):1937–44.
Copper MP, Triesscheijn M, Tan IB, Ruevekamp MC, Stewart FA. Photodynamic therapy in the treatment of multiple primary tumours in the head and neck, located to the oral cavity and oropharynx. Clin Otolaryngol. 2007;32:185–9.
Tan IB, Dolivet G, Ceruse P, Vander Poorten V, Roest G, Rauschning W. Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study. Head Neck. 2010;32:1597–604.
Lou PJ, Jager HR, Jones L, Theodossy T, Bown SG, Hopper C. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer. 2004;91:441–6.
Karakullukcu B, Nyst HJ, van Veen RL, Hoebers FJ, Hamming-Vrieze O, Witjes MJ, de Visscher SA, Burlage FR, Levendag PC, Sterenborg HJ, Tan IB. mTHPC mediated interstitial photodynamic therapy of recurrent nonmetastatic base of tongue cancers: development of a new method. Head Neck. 2012;34(11):1597–606.
Karakullukcu B, van Veen RL, Aans JB, Hamming-Vrieze O, Navran A, Teertstra HJ, van den Boom F, Niatsetski Y, Sterenborg HJ, Tan IB. MR and CT based treatment planning for mTHPC mediated interstitial photodynamic therapy of head and neck cancer: description of the method. Lasers Surg Med. 2013;45(8):517–23.
Jerjes W, Upile T, Hamdoon Z, Nhembe F, Bhandari R, Mackay S, et al. Ultrasound-guided photodynamic therapy for deep seated pathologies: prospective study. Lasers Surg Med. 2009;41:612–21.
Jerjes W, Upile T, Alexander Mosse C, Hamdoon Z, Morcos M, Morley S, et al. Prospective evaluation of 110 patients following ultrasound-guided photodynamic therapy for deep seated pathologies. Photodiagn Photodyn Ther. 2011;8:297–306.
Jerjes W, Upile T, Hamdoon Z, Abbas S, Akram S, Mosse CA, et al. Photodynamic therapy: the minimally invasive surgical intervention for advanced and/or recurrent tongue base carcinoma. Lasers Surg Med. 2011;43:283–92.
Kreeft A, Tan IB, van den Brekel MW, Hilgers FJ, Balm AJ. The surgical dilemma of ‘functional inoperability’ in oral and oropharyngeal cancer: current consensus on operability with regard to functional results. Clin Otolaryngol. 2009;34(2):140–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Karakullukcu, M.B. (2016). Photodynamic Therapy of Oropharyngeal Malignancies. In: Wong, BF., Ilgner, J. (eds) Biomedical Optics in Otorhinolaryngology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1758-7_22
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1758-7_22
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1757-0
Online ISBN: 978-1-4939-1758-7
eBook Packages: MedicineMedicine (R0)